Zeripatamig is under clinical development by Light Chain Bioscience and currently in Phase I for Mantle Cell Lymphoma.

The following is a summary of “Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers of Cognitive Decline in People With Human Immunodeficiency Virus,” published in the ...

Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines Agency (EMA) for ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

one causing glomerular albumin loss and the other causing monoclonal light chain proteinuria. Our case series has several limitations. First, it was retrospective. Second, it occurred at a single ...

Indeed, Regeneron believes that the success with Ebola could potentially have ushered in “a new era in which monoclonal antibodies could be used to fight viral diseases and global pandemics.” ...

With limited treatment options available for patients with PDAC, the EMA Orphan Drug Designation and FDA Orphan Drug Designation granted to elraglusib for the same indication reflect elraglusib’s ...

7 The disease was classified as in partial ... and 27 per cent had γA myeloma proteins. The light-chain determinant kappa was present in 65 per cent of the proteins, and the lambda determinant ...

They are very manageable diseases both through lifestyle management ... which have different supply chains than big box pharmacies. Cost is another big factor. The American Diabetes Association ...

president of Kappa Create Co., which operates the Kappa Sushi chain, on suspicion of violating the Unfair Competition Prevention Law. Before becoming an adviser to Kappa Create in November 2020 ...

This unsettling event has reignited discussions about “Disease X.” Disease X is not an actual but a hypothetical disease. The World Health Organization (WHO) coined the term in 2018 to ...